Mikhail Rakhmanine, MD
Colon & Rectal Surgery · Allentown, PANPI 1326028705
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,037 of the $2,287 with a category attached, or 89.1%. 18 manufacturers reported payments, led by Medtronic at 28.8% of the total. That places this record below the midpoint for colon & rectal surgery clinicians in PA, where the typical reported total is $2,089.
Across 89 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$659
- Takeda Pharmaceuticals U.S.A., Inc.$609
- Ferring Pharmaceuticals Inc.$216
- Integra Lifesciences Corporation$114
- Axonics, Inc.$113
- Exact Sciences$82
- plus $495 from 12 others
What the payments were for
- Consulting fees$2059%
- Speaking & faculty fees$452%
- Food & beverage$2,03789%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $659 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $609 |
| Ferring Pharmaceuticals Inc. | 11 | $216 |
| Integra Lifesciences Corporation | 4 | $114 |
| Axonics, Inc. | 6 | $113 |
| Exact Sciences | 3 | $82 |
| AbbVie | 2 | $80 |
| Braintree Laboratories, Inc. | 5 | $80 |
| BD | 2 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $46 |
| Laborie Medical Technologies Corp. | 1 | $44 |
| Shire North American Group Inc | 2 | $40 |
| Innovation Technologies Inc | 2 | $33 |
| Johnson & Johnson(2 entities) | 2 | $28 |
| Palette Life Sciences, Inc. | 1 | $27 |
| KCI USA, Inc. | 1 | $21 |
| Merck | 1 | $14 |
| THD America, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GATTEX$125
How this compares
$2,287 in reported general payments places this provider in the 50th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 45 | $7,068 |
| LinzessLinaclotide | 13 | $6,889 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 39 | $6,505 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 92 | $6,109 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 20 | $3,193 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 11 | $1,636 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 94 | $1,477 |
| Colestipol Hcl | 29 | $785 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 35 | $603 |
| CholestyramineCholestyramine (With Sugar) | 12 | $545 |
| Neomycin Sulfate | 36 | $183 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 13 | $165 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $109 |
| Sulfasalazine DrSulfasalazine | 11 | $86 |
| Metronidazole | 45 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $80 | $6,88913 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $216 | $6,50539 claims |
| Braintree Laboratories, Inc.Sutab | $80 | $3,19320 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $46 | $1,63611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Other colon & rectal surgery in Allentown
- John ParkAllentown$7K
- William SangsterAllentown$6K
- Michael JohnsAllentown$5K
- Bogdan ProtyniakWilkes-Barre$429K
- John MarksWynnewood$155K
- Joshua BleierPhiladelphia$86K
- Richard FortunatoPittsburgh$80K
- Najjia MahmoudPhiladelphia$63K
- James McCormickMonroeville$55K
- Juan PoggioPhiladelphia$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.